Dr. Jay Zhang joined Panacea Venture in 2018 as a Venture Partner. He is the Co-Founder & CEO of TriArm Therapeutics and Interim CEO of Tactiva Therapeutics. He previously was General Manager of Dragonboat Biopharmaceutical, and the Founding CEO of Dragon Sail Biopharmaceuticals. He led the R&D, business development, IND registration & clinical trial, manufacturing setup & construction, merger & acquisition.
Jay also worked as Senior Scientist, Associate Director, Director, Founder etc. in various biotech companies including NYU Medical Center, GenMetrics, Infogene, Hyseq Pharmaceuticals, Protogene Laboratories, Anesiva etc.
Jay received a PhD in Neuroscience/Genomics from the University of Utah and did his post-doctoral training in Genetics at Stanford University. Jay is based in Shanghai, Taipei and San Francisco Bay Area.